Risk adapted regulation of clinical trials

Research Ethics 10 (1):2-5 (2014)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1177/1747016114524520

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,672

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2012 - Bioethics 28 (3):138-146.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.
Disputing the ethics of research: The challenge from bioethics and patient activism to the interpretation of the declaration of helsinki in clinical trials.Simon Woods & Pauline Mccormack - 2012 - Bioethics 27 (5):243-250.
The Duty to Disclose Adverse Clinical Trial Results.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):24-32.
A European consistency for functioning of RECs? We just lost our chance.Marcin Waligora - 2013 - Journal of Medical Ethics 39 (6):408-409.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
Restricted treatments, inducements, and research participation.Sarah J. L. Edwards - 2006 - Bioethics 20 (2):77–91.
Valuing risk: The ethical review of clinical trial safety.Jonathan Kimmelman - 2004 - Kennedy Institute of Ethics Journal 14 (4):369-393.
Hidden risks associated with clinical trials in developing countries.C. Lorenzo, V. Garrafa, J. H. Solbakk & S. Vidal - 2010 - Journal of Medical Ethics 36 (2):111-115.
A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?".Douglas R. Wassenaar & Gita Ramjee - 2009 - BMC Medical Ethics 10 (1):16-.
Retractions in the medical literature: how can patients be protected from risk?R. Grant Steen - 2012 - Journal of Medical Ethics 38 (4):228-232.
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
The science and ethics of placebo in pediatric psychopharmacology.Lawrence Scahill, Mary Solanto & Joseph McGuire - 2008 - Ethics and Behavior 18 (2-3):266 – 285.

Analytics

Added to PP
2014-03-14

Downloads
7 (#1,382,106)

6 months
1 (#1,462,504)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Sarah Edwards
State University of New York, Buffalo

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references